Kiss Goodbye to MS is celebrating a big milestone this September. So far, in 2017, the campaign has

Cladribine, an oral treatment for relapsing remitting MS, previously approved in Australia, but subsequently withdrawn, is making a

Australian researchers discover a gene which might influence MS relapse rates. Our genes influence everything about us, including

MS Research Australia has been reporting on every step that Ocrevus a new MS medication, has taken on

MS Research Australia are very proud to have been approached by the MS International Federation (MSIF) to write

Scientific evidence suggests that a number of genes are involved in the development of MS. Previously, MS Research

The number of people living with MS and other autoimmune disorders has been increasing. Many reasons for this

MS is a debilitating disease that affects the communication of messages from nerve cells in the brain to

The Australian Therapeutic Goods Administration (TGA) has approved Ocrevus (ocrelizumab) for the treatment of multiple sclerosis in Australia.